Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/29/2010 | EP2267153A1 Identification of netrin-1 receptor unc5c gene mutation in solid cancers |
12/29/2010 | EP2267141A1 Process for the biological production of n-Butanol with high yield |
12/29/2010 | EP2267140A1 Improved genetic elements providing high levels of expression |
12/29/2010 | EP2267139A2 Methods and means for obtaining modified phenotypes |
12/29/2010 | EP2267138A2 Methods and means for obtaining modified phenotypes |
12/29/2010 | EP2267137A2 Production system of terpenoids in plants |
12/29/2010 | EP2267136A2 Glyphosate tolerant alfalfa events and methods for detection thereof |
12/29/2010 | EP2267135A2 Protein glycosylation modification in pichia pastoris |
12/29/2010 | EP2267134A1 Isolated fungal promoters and gene transcription terminators and methods of protein and chemical production in a fungus |
12/29/2010 | EP2267133A2 Method for making poly(3-hydroxyproprionate) |
12/29/2010 | EP2267132A2 Polyepitopic protein fragments of HPV proteins E6 and E7, method for obtaining same and uses thereof, in particular for vaccination |
12/29/2010 | EP2267131A1 Genetic inhibition by double-stranded RNA |
12/29/2010 | EP2267130A2 Bitter taste receptors |
12/29/2010 | EP2267129A2 Bitter taste receptors |
12/29/2010 | EP2267128A2 Bitter taste receptors |
12/29/2010 | EP2267127A1 Improved methods for extracting nucleic acids from tissue samples and paraffin-embedded tissues |
12/29/2010 | EP2267126A1 Process for the stable gene interruption in clostridia |
12/29/2010 | EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor |
12/29/2010 | EP2267124A1 Improved hydroxynitrile lyase |
12/29/2010 | EP2267123A2 Compositions and methods for modulating lignin of a plant |
12/29/2010 | EP2267120A1 Recombinant vaccinia virus having hepatitis c virus gene |
12/29/2010 | EP2267119A1 Method for concentration of virus |
12/29/2010 | EP2267118A1 Method for production of transfected cell |
12/29/2010 | EP2267034A2 Gold-binding protein and use thereof |
12/29/2010 | EP2267033A2 Gold-binding protein and use thereof |
12/29/2010 | EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
12/29/2010 | EP2267028A2 DUAL SPECIFIC SINGLE DOMAIN ANTIBODIES (dAb) conjugated to PEG |
12/29/2010 | EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
12/29/2010 | EP2267026A1 Albumin fusion proteins |
12/29/2010 | EP2267023A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267022A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267021A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267010A2 Activatable recombinant neurotoxins |
12/29/2010 | EP2267009A2 Activatable recombinant neurotoxins |
12/29/2010 | EP2267008A2 Activatable recombinant neurotoxins |
12/29/2010 | EP2267007A1 New gene products of bacillus licheniformis forming or decomposing polyamino acids and associated improved biotechnological production method |
12/29/2010 | EP2267006A1 Enterococcus antigens |
12/29/2010 | EP2267005A1 ADP-ribosylating toxin from Listeria monocytogenes |
12/29/2010 | EP2267004A2 Peptide derived from hepatitis C virus |
12/29/2010 | EP2267002A2 Antimicrobial polypeptides |
12/29/2010 | EP2267001A2 Antimicrobial polypeptides |
12/29/2010 | EP2267000A2 Antimicrobial polypeptides |
12/29/2010 | EP2266997A1 Modulation of C-reactive protein expression |
12/29/2010 | EP2266995A1 Oligonucleotides against HIV infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
12/29/2010 | EP2266656A2 Devices for delivering a biologically active agent to the ocular sphere of a subject |
12/29/2010 | EP2266627A1 Single-stranded oligodeoxynucleotide mutational vectors |
12/29/2010 | EP2266543A2 Non-polymeric hematopoietic cell clots for delivery of active agents |
12/29/2010 | EP2266396A2 Modulation of stem cells using zinc finger proteins |
12/29/2010 | EP2265732A2 Genetics variants associated with hiv disease restriction |
12/29/2010 | EP2265730A2 Methods and compositions for translational profiling and molecular phenotyping |
12/29/2010 | EP2265719A2 Heat resistant plants and plant tissues and methods and materials for making and using same |
12/29/2010 | EP2265718A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing |
12/29/2010 | EP2265717A2 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
12/29/2010 | EP2265716A1 Polypeptide having glyoxalase iii activity, polynucleotide encoding the same and uses thereof |
12/29/2010 | EP2265715A2 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
12/29/2010 | EP2265713A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
12/29/2010 | EP2265642A1 Biomarkers |
12/29/2010 | EP2265641A1 Biomarkers |
12/29/2010 | EP2265638A1 Stable cell binding chimeric peptides |
12/29/2010 | EP2265633A2 Antigenic protein fragments of streptococcus pneumoniae |
12/29/2010 | EP2265284A2 Replication-defective flavivirus vaccines and vaccine vectors |
12/29/2010 | EP2265282A1 Novel crustacean androgenic gland hormone |
12/29/2010 | EP2265276A2 Compositions and methods for inhibiting expression of eg5 and vegf genes |
12/29/2010 | EP2265111A1 Hairless immunodeficient mouse model |
12/29/2010 | EP2041286B1 Process for making oligopeptides |
12/29/2010 | EP1853706B1 Sample preparation method incorporating an alkaline shock |
12/29/2010 | EP1807521B1 Plants having improved growth characteristics and method for making the same |
12/29/2010 | EP1723255B1 Method for enrichment involving elimination by mismatch hybridisation |
12/29/2010 | EP1694697B1 Surface-located campylobacter jejuni polypeptides |
12/29/2010 | EP1673398B1 Multispecific deimmunized cd3-binders |
12/29/2010 | EP1666584B1 Method of breeding lipid-producing fungus |
12/29/2010 | EP1631685B1 Nucleic acid processing methods, kits and devices |
12/29/2010 | EP1576123B1 Process for the biological production of 1,3-propanediol with high yield |
12/29/2010 | EP1539228B1 Novel composition and methods for the treatment of immune related diseases |
12/29/2010 | EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction |
12/29/2010 | EP1513952B1 Composition and methods for obtaining nucleic acids from sputum |
12/29/2010 | EP1504095B2 Site specific listeria integration vectors and methods for using the same |
12/29/2010 | EP1497415B1 Methods for detection or modulation of the interaction of a cytokine receptor with its ligand |
12/29/2010 | EP1496122B1 Novel meloidogyne-resistance gene and utilization thereof |
12/29/2010 | EP1494705B1 A composition and method for killing of tumours |
12/29/2010 | EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
12/29/2010 | EP1404849B1 Modification of plant genomes by inducible site-specific recombination of transgenes |
12/29/2010 | EP1315816B1 Genetically engineered co-expression dna vaccines, construction methods and uses thereof |
12/29/2010 | EP1315519B1 Pharmaceutical compositions and methods useful for treating cancer or liver fibrosis |
12/29/2010 | EP1256625B1 Immortalized vascular adventitial cell line |
12/29/2010 | EP1165133B1 Anti-human mitochondrial adenylate kinase isozyme antibody, diagnostic formulation and diagnostic kit for cardiac disease |
12/29/2010 | EP1127069B1 Method of making a monomeric beta-form of a prion protein |
12/29/2010 | EP0781329B2 Overexpression of mammalian and viral proteins |
12/29/2010 | CN201686641U DNA automatic extraction robot |
12/29/2010 | CN1995345B Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland |
12/29/2010 | CN1993482B Instrument for detecting bacterium, method of detecting bacterium and kit for detecting bacterium |
12/29/2010 | CN1989439B Methods and compositions for the treatment of uveitis |
12/29/2010 | CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application |
12/29/2010 | CN1886507B Rice and products thereof having starch with an increased proportion of amylose |